Get the latest research and practical clinical applications from the 24th Annual Meeting of the Society of Urologic Oncology.
Conference Coverage
Coverage of the major medical conferences that impact genitourinary oncology professionals.
Advertisement
Exclusive coverage from The Uromigos Live & Unplugged 2023
In-depth coverage of 2023 IKCS: North America
In-depth coverage of the ESMO 2023 Congress, featuring the latest research and science on urology.
In-depth coverage of the ESMO 2023 Congress, featuring the latest research and science on bladder cancer.
In-depth coverage of ASTRO 2023
In-depth coverage of the SNMMI 2023 Annual Meeting
In-depth coverage of the 2023 ASCO Annual Meeting
In-depth coverage of the AUA 2023 Annual Meeting, featuring the latest research and science on urology
In-depth coverage of the AUA 2023 Annual Meeting, featuring the latest research and science on bladder cancer
Coverage of the 2023 ASCO GU Symposium
Advertisement
2022
Kidney Cancer News and Research from 2022 IKCS: NORTH AMERICA
Prostate Cancer News and Research from SUO 2022
Prostate Cancer News and Research from the 2022 ASTRO Annual Meeting
Exclusive coverage from The Uromigos Live & Unplugged
Coverage of ESMO 2022
Coverage of the SNMMI 2022 Meeting
Coverage of the ASCO 2022 Annual Meeting
Coverage of AUA 2022
Coverage of the 2022 ASCO GU Symposium
2021
Coverage of AUA 2021
Coverage of the SUO Annual Meeting 2021
Coverage of the ASCO 2021 Annual Meeting
Coverage of the 2021 ASCO GU Symposium
GU Oncology Now delivers the latest genitourinary oncology conference coverage, highlighting advancements in treatments and tech.
Get exclusive conference news straight to your inbox.
Knowledge Hub Spotlights
Curated clinical content based on conditions, therapies, and technologies
Roundtables
Clinical discussions with experts in the field
The panel discussed optimal treatment cycles for enfortumab vedotin/pembrolizumab.
The panel shared their thoughts on the EV-302 study.
The panel kicked off with conversations about data released at ESMO, including EV-302 and CheckMate 901.
The panel shares their hopes for the future of bladder cancer treatment.
The panel shares tips for community oncologists who may not be familiar with treating patients with EV/pembro.
The panel shares treatment sequencing decisions based on a few patient scenarios.
